Clinical Trial Update: A Trial Assessing The Effectiveness and Safety of [S,S]-Reboxetine in Patients With Fibromyalgia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the effectiveness and safety of S,S-Reboxetine in patients with fibromyalgia has completed. The study was sponsored by Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• S,S-Reboxetine (reboxetine)

Snippet

Sponsor: Pfizer | Conditions: Pain | Phase 2 | Status: COMPLETED